ES2194444T3 - Agonistas y antagonistas de 20-hete. - Google Patents

Agonistas y antagonistas de 20-hete.

Info

Publication number
ES2194444T3
ES2194444T3 ES99908425T ES99908425T ES2194444T3 ES 2194444 T3 ES2194444 T3 ES 2194444T3 ES 99908425 T ES99908425 T ES 99908425T ES 99908425 T ES99908425 T ES 99908425T ES 2194444 T3 ES2194444 T3 ES 2194444T3
Authority
ES
Spain
Prior art keywords
hete
agonists
antagonists
acid
hydroxyeicosa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99908425T
Other languages
English (en)
Inventor
Richard J Roman
John R Falck
Magdalena Alonso-Galicia
Elizabeth R Jacobs
David R Harder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Medical College of Wisconsin Research Foundation Inc
Original Assignee
University of Texas System
Medical College of Wisconsin Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System, Medical College of Wisconsin Research Foundation Inc filed Critical University of Texas System
Application granted granted Critical
Publication of ES2194444T3 publication Critical patent/ES2194444T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Un compuesto de la fórmula: en la que: R1 se elige entre ácido carboxílico; fenol; amida; imida; sulfonamida; sulfonimida; metileno activo; 1, 3- dicarbonilo; alcohol; tiol; amina; tetrazol y otros grupos heteroarilo, R2 se elige entre ácido carboxílico; fenol; amida; imida; sulfonamida; sulfonimida; metileno activo; 1, 3- dicarbonilo; alcohol; tiol; amina; tetrazol y otros grupos heteroarilo, W es una cadena hidrocarbonada de C1 a C25 y puede ser lineal, cíclica o ramificada y puede comprender heteroátomos, Y es una cadena hidrocarbonada de C1 a C25 y puede ser lineal, cíclica, o ramificada y puede comprender heteroátomos, Sp<3 Centro se elige entre restos vinileno; arileno; heteroarileno; ciclopropileno; y etinileno, X es una cadena alquílica que puede ser lineal, ramificada, cíclica o policíclica y puede comprender heteroátomos, m es 0, 1, 2, 3, 4, ó 5 y n es 0, 1, 2, 3, 4 ó 5, para uso en el tratamiento del cuerpo animal o humano mediante terapia.
ES99908425T 1998-02-26 1999-02-24 Agonistas y antagonistas de 20-hete. Expired - Lifetime ES2194444T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7609198P 1998-02-26 1998-02-26

Publications (1)

Publication Number Publication Date
ES2194444T3 true ES2194444T3 (es) 2003-11-16

Family

ID=22129876

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99908425T Expired - Lifetime ES2194444T3 (es) 1998-02-26 1999-02-24 Agonistas y antagonistas de 20-hete.

Country Status (13)

Country Link
US (3) US6395781B1 (es)
EP (1) EP1056449B1 (es)
JP (1) JP3921583B2 (es)
KR (1) KR100390312B1 (es)
CN (1) CN1148179C (es)
AT (1) ATE237321T1 (es)
AU (1) AU750579B2 (es)
CA (1) CA2320706C (es)
DE (1) DE69906944T2 (es)
DK (1) DK1056449T3 (es)
ES (1) ES2194444T3 (es)
PT (1) PT1056449E (es)
WO (1) WO1999043310A2 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395781B1 (en) * 1998-02-26 2002-05-28 Mcw Research Foundation 20-HETE antagonists and agonists
US8008283B2 (en) * 1998-12-23 2011-08-30 Neurotherapeutics Pharma, Inc. Methods and compositions for the treatment of neuropsychiatric disorders
US7214711B2 (en) * 1998-12-23 2007-05-08 Neurotherapeutics Pharma Llc Method of treating migraine headache without aura
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
JP4045099B2 (ja) 1999-11-01 2008-02-13 大正製薬株式会社 ２０−ｈｅｔｅ産生酵素阻害剤
US7307101B2 (en) 2000-11-03 2007-12-11 Mcw Research Foundation, Inc. Use of 20-HETE synthesizing enzyme inhibitors as therapy for cerebral vascular disease
US20020151734A1 (en) * 2001-01-02 2002-10-17 Schwartzman Michal Laniado 12-HETrE analogs and methods of use thereof
KR100819322B1 (ko) 2001-04-26 2008-04-02 다이쇼 세이야꾸 가부시끼가이샤 20-히드록시에이코사테트라엔산 생산 저해제
US6818662B2 (en) * 2002-05-28 2004-11-16 Taisho Pharmaceutical Co., Ltd. Pharmaceutical composition
AU2003235454A1 (en) 2002-06-14 2003-12-31 Alcon, Inc. Use of hydroxyeicosatetraenoic acid compounds to treat ophthalmic inflammatory disorders
US20050124618A1 (en) * 2003-11-14 2005-06-09 Roman Richard J. Methods of modulating angiogenesis and cancer cell proliferation
US20080306155A1 (en) * 2004-09-16 2008-12-11 Roman Richard J Method for treating renal disease
US20070004802A1 (en) * 2004-09-16 2007-01-04 Roman Richard J Method for treating renal disease
US20060063836A1 (en) * 2004-09-16 2006-03-23 Roman Richard J Method for treating renal disease
WO2007047447A2 (en) * 2005-10-17 2007-04-26 Neurotherapeutics Pharma, Inc. Diuretic-like compound analogs useful for regulation of central nervous system disorders
WO2008034011A2 (en) 2006-09-13 2008-03-20 Mcw Research Foundation, Inc. Methods of modulating cell proliferation and cyst formation in polycystic kidney and liver diseases
US20090069418A1 (en) * 2007-04-25 2009-03-12 Alkayed Nabil J Compositions and Methods for the Treatment of Disorders Associated with Aberrant Vasodilation
EP2208720A1 (en) * 2009-01-13 2010-07-21 Max-Delbrück-Centrum für Molekulare Medizin (MDC) Novel eicosanoid derivatives
WO2015089102A1 (en) * 2013-12-10 2015-06-18 The Regents Of The University Of California Differential diagnosis of liver disease
CN110950786A (zh) 2014-01-22 2020-04-03 分子医学马克斯德尔布吕克中心 新型cyp-类二十烷酸衍生物
US11690825B2 (en) 2016-03-09 2023-07-04 Board Of Regents, The University Of Texas System 20-HETE receptor (GPR75) antagonists and methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5334736A (en) 1991-05-16 1994-08-02 University Of Texas System Board Of Regents Functionalizing carbohydrate derivatives by base-induced β-eliminatiom forming bioactive derivatives containing hydroxy-diene subunits
US5502226A (en) * 1994-11-14 1996-03-26 Elizabeth Arden Co., Division Of Conopco, Inc. Process of preparing ω-hydroxy acids
US5753702A (en) 1996-05-22 1998-05-19 University Of Vermont Arachidonic acid metabolite, 16-hete
US6395781B1 (en) * 1998-02-26 2002-05-28 Mcw Research Foundation 20-HETE antagonists and agonists

Also Published As

Publication number Publication date
US6605641B2 (en) 2003-08-12
US6395781B1 (en) 2002-05-28
DK1056449T3 (da) 2003-08-11
DE69906944D1 (de) 2003-05-22
EP1056449B1 (en) 2003-04-16
DE69906944T2 (de) 2003-12-24
CA2320706A1 (en) 1999-09-02
CN1291890A (zh) 2001-04-18
ATE237321T1 (de) 2003-05-15
AU750579B2 (en) 2002-07-25
AU2786199A (en) 1999-09-15
CN1148179C (zh) 2004-05-05
KR100390312B1 (ko) 2003-07-12
EP1056449A2 (en) 2000-12-06
US20020049244A1 (en) 2002-04-25
US6596769B2 (en) 2003-07-22
US20020072534A1 (en) 2002-06-13
KR20010034544A (ko) 2001-04-25
JP2003522098A (ja) 2003-07-22
PT1056449E (pt) 2003-09-30
JP3921583B2 (ja) 2007-05-30
WO1999043310A2 (en) 1999-09-02
WO1999043310A3 (en) 1999-10-07
CA2320706C (en) 2007-05-01

Similar Documents

Publication Publication Date Title
ES2194444T3 (es) Agonistas y antagonistas de 20-hete.
DK1104425T3 (da) Hidtil ukendte thiazolopyrimidinforbindelser
BR9916896A (pt) Diaril aminas substituìdas com 1-heterociclo
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
NO994906L (no) GnRH antagonister som er modifisert i stillinger 5 og 6
DK0960107T3 (da) 6-Thiosubstituerede paclitaxeler
BR9813817A (pt) Análogos de hemiasterlina
BG105256A (en) Muscarinic agonists and antagonists
DE59006757D1 (de) Knochennagel und Werkzeug für denselben.
BG103968A (en) Pharmaceutical antiviral composition containing glycirricinic acid and at least one protein with antiviral activity
DE975695T1 (de) Zusammensetzungen, enthaltend gleit- und antiblockmittel
PT929299E (pt) 1,2,3,4-tetra-hidro-2-dibenzofuranaminas e 2-aminociclo-hepta ¬b| benzofuranos substituidos
ATE28188T1 (de) Antikonvulsive mittel.
GB9811221D0 (en) Bacterial-pheromones and uses therefor
ATE57526T1 (de) P-acylaminobenzamide.
DK1011329T3 (da) 7-Methylthiooxomethyl- og 7-methylthiodioxomethyl-paclitaxeler
RS47804A (en) 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof
ZA978233B (en) The use of protein as anti-retroviral agents.
ITTO940212V0 (it) Attrezzatura per compassi sostitutiva dell&#39;ago.
ITVC980018A0 (it) Biscotti &#34;le risaiole&#34;.
ES2127142B1 (es) Corbata reversible.